Literature DB >> 19221466

Localized accumulation of oxidative stress causes muscle atrophy through activation of an autophagic pathway.

Michela Aucello1, Gabriella Dobrowolny, Antonio Musarò.   

Abstract

A crucial system severely affected in different chronic diseases is the antioxidative defense, leading to accumulation of reactive oxygen species (ROS). The discovery that deletion in the antioxidant genes shortens significantly the mouse life span, and that mutation in the major antioxidant enzyme SOD1 is associated with neurodegenerative diseases, has placed oxidative stress as a central mechanism in the pathogenesis of many pathological conditions. However, how such an oxidative insult plays a role in the disease-related decrease of muscle performance and mass remains largely unknown. We recently demonstrated that autophagy plays a dominant role in the promotion of muscle atrophy associated with local alteration in the activity of the antioxidant enzyme SOD1. In particular, transcription of autophagy-related genes, such as those encoding LC3, Cathepsin-L and Bnip3, is activated in response to localized accumulation of oxidative stress and is mediated by FoxO3. In addition, our study documents how the T-tubule might be the potential donor of membrane that forms sequestering autophagic vesicles. Here we discuss the sequence of events leading to muscle atrophy.

Entities:  

Mesh:

Year:  2009        PMID: 19221466     DOI: 10.4161/auto.5.4.7962

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  27 in total

Review 1.  ROS and Autophagy: Interactions and Molecular Regulatory Mechanisms.

Authors:  Lulu Li; Jin Tan; Yuyang Miao; Ping Lei; Qiang Zhang
Journal:  Cell Mol Neurobiol       Date:  2015-02-27       Impact factor: 5.046

Review 2.  Unraveling new mechanisms of exercise intolerance in chronic heart failure: role of exercise training.

Authors:  Viviane M Conraads; Emeline M Van Craenenbroeck; Catherine De Maeyer; An M Van Berendoncks; Paul J Beckers; Christiaan J Vrints
Journal:  Heart Fail Rev       Date:  2013-01       Impact factor: 4.214

Review 3.  Mechanistic links between oxidative stress and disuse muscle atrophy.

Authors:  Scott K Powers; Ashley J Smuder; David S Criswell
Journal:  Antioxid Redox Signal       Date:  2011-06-17       Impact factor: 8.401

4.  Autophagy inhibition uncovers the neurotoxic action of the antipsychotic drug olanzapine.

Authors:  Ljubica Vucicevic; Maja Misirkic-Marjanovic; Verica Paunovic; Tamara Kravic-Stevovic; Tamara Martinovic; Darko Ciric; Nadja Maric; Sasa Petricevic; Ljubica Harhaji-Trajkovic; Vladimir Bumbasirevic; Vladimir Trajkovic
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

5.  Bnip3-mediated mitochondrial autophagy is independent of the mitochondrial permeability transition pore.

Authors:  Melissa N Quinsay; Robert L Thomas; Youngil Lee; Asa B Gustafsson
Journal:  Autophagy       Date:  2010-10       Impact factor: 16.016

6.  Contractile activity attenuates autophagy suppression and reverses mitochondrial defects in skeletal muscle cells.

Authors:  Alexa Parousis; Heather N Carter; Claudia Tran; Avigail T Erlich; Zahra S Mesbah Moosavi; Marion Pauly; David A Hood
Journal:  Autophagy       Date:  2018-08-04       Impact factor: 16.016

Review 7.  Murine models of atrophy, cachexia, and sarcopenia in skeletal muscle.

Authors:  Mark Romanick; Ladora V Thompson; Holly M Brown-Borg
Journal:  Biochim Biophys Acta       Date:  2013-03-20

8.  Molecular and cellular mechanisms of skeletal muscle atrophy: an update.

Authors:  Alessandro Fanzani; Viviane M Conraads; Fabio Penna; Wim Martinet
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-06-07       Impact factor: 12.910

9.  Reactive oxygen species in skeletal muscle signaling.

Authors:  Elena Barbieri; Piero Sestili
Journal:  J Signal Transduct       Date:  2011-12-05

Review 10.  Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training.

Authors:  T Scott Bowen; Gerhard Schuler; Volker Adams
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-06-03       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.